A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

NCT07004972 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Symptomatic Obstructive Hypertrophic Cardiomyopathy

Interventions

DRUG: Mavacamten

Sponsor

Bristol-Myers Squibb